Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.

[1]  P. Høilund-Carlsen,et al.  Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  A. Alavi,et al.  Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer , 2017, The Journal of Nuclear Medicine.

[3]  Jeong Hyun Lee,et al.  18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer. , 2017, European journal of cancer.

[4]  M. Kırış,et al.  Pathologic Evaluation of Routine Nasopharynx Punch Biopsy in the Adult Population: Is It Really Necessary? , 2016, Clinical and experimental otorhinolaryngology.

[5]  M. Merlano,et al.  Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience , 2016, Clinical and experimental otorhinolaryngology.

[6]  J. Cho,et al.  Trends in Head and Neck Cancer in South Korea Between 1999 and 2012 , 2016, Clinical and experimental otorhinolaryngology.

[7]  J. Park,et al.  Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT , 2016, Clinical and experimental otorhinolaryngology.

[8]  J. Roh,et al.  18F-FDG PET/CT surveillance at 3–6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma , 2013, British Journal of Cancer.

[9]  J. Roh,et al.  Second Cancer Incidence, Risk Factor, and Specific Mortality in Head and Neck Squamous Cell Carcinoma , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  J. Roh,et al.  Distant Metastases and Survival Prediction in Head and Neck Squamous Cell Carcinoma , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[11]  M. Tsukuda,et al.  Diagnostic sensitivity of 18fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients , 2012, European Archives of Oto-Rhino-Laryngology.

[12]  K. Trinkaus,et al.  Squamous cell cancer of the head and neck with distant metastasis at presentation , 2011, Head & neck.

[13]  Vincent Grégoire,et al.  Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Y. Shang,et al.  Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  A. Garden,et al.  Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Nancy Lee,et al.  PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma , 2009, Journal of Nuclear Medicine.

[17]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[18]  J. Roodenburg,et al.  FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. , 2009, Oral oncology.

[19]  S. Stoeckli,et al.  Head and neck squamous cell carcinoma (HNSCC) – detection of synchronous primaries with 18F-FDG-PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  T. Ogawa,et al.  Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer. , 2008, Archives of otolaryngology--head & neck surgery.

[21]  C. Hamashima,et al.  Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy , 2007, British Journal of Cancer.

[22]  J. Roh,et al.  Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  E. Blackstone,et al.  Is FDG-PET indicated for superficial esophageal cancer? , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  R. Spreafico,et al.  Risk factors for distant metastases in head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[25]  Kyung Soo Lee,et al.  Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[27]  C. Silver,et al.  Incidence and Sites of Distant Metastases from Head and Neck Cancer , 2001, ORL.

[28]  S. Stringer,et al.  Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  P. V. van Rijk,et al.  18F‐fluorodeoxyglucose dual‐head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer , 1999, Cancer.

[30]  P. Van cauwenberge,et al.  Multiple Primary Malignant Tumors in Patients With Head and Neck Cancer , 1998, The Laryngoscope.

[31]  T. Helliwell,et al.  Second primary tumors in patients with head and neck squamous cell carcinoma , 1995, Cancer.

[32]  E. Touboul,et al.  Synchronous and metachronous head and neck carcinomas , 1994, Cancer.

[33]  S. Lippman,et al.  Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. , 1989, International journal of radiation oncology, biology, physics.

[34]  J. Roh,et al.  Predictive factors for long-term survival in head and neck squamous cell carcinoma patients with distant metastasis after initial definitive treatment , 2015, Journal of Cancer Research and Clinical Oncology.

[35]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[36]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.